# CNA Financial Corp: financial statements, quarterly

CNA · NYSE · CIK 21175 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cna.md) · [Financials](/companies/cna/financials.md) · [Filings](/companies/cna/filings.md) · [Insiders](/companies/cna/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cna/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [407](/filings/0000021175-24-000095.md) | [403 d](/filings/0000021175-26-000011.md) | [407](/filings/0000021175-25-000049.md) | [404](/filings/0000021175-25-000074.md) | [401](/filings/0000021175-25-000097.md) | [397 d](/filings/0000021175-26-000011.md) | [397](/filings/0000021175-26-000031.md) | [398](/filings/0000021175-26-000045.md) | [393](/filings/0000021175-25-000097.md) | [389 d](/filings/0000021175-26-000011.md) | [374](/filings/0000021175-26-000031.md) | [367](/filings/0000021175-26-000045.md) |
| Interest expense | $m | [34.0](/filings/0000021175-24-000095.md) | [34.0 d](/filings/0000021175-26-000011.md) | [35.0](/filings/0000021175-25-000049.md) | [34.0](/filings/0000021175-25-000074.md) | [32.0](/filings/0000021175-25-000097.md) | [32.0 d](/filings/0000021175-26-000011.md) | [32.0](/filings/0000021175-26-000031.md) | [31.0](/filings/0000021175-26-000045.md) | [36.0](/filings/0000021175-25-000097.md) | [36.0 d](/filings/0000021175-26-000011.md) | [33.0](/filings/0000021175-26-000031.md) | [33.0](/filings/0000021175-26-000045.md) |
| Income tax | $m | [68.0](/filings/0000021175-24-000095.md) | [93.0 d](/filings/0000021175-26-000011.md) | [89.0](/filings/0000021175-25-000049.md) | [85.0](/filings/0000021175-25-000074.md) | [78.0](/filings/0000021175-25-000097.md) | [0.0 d](/filings/0000021175-26-000011.md) | [75.0](/filings/0000021175-26-000031.md) | [81.0](/filings/0000021175-26-000045.md) | [110](/filings/0000021175-25-000097.md) | [76.0 d](/filings/0000021175-26-000011.md) | [56.0](/filings/0000021175-26-000031.md) | [84.0](/filings/0000021175-26-000045.md) |
| Net income | $m | [258](/filings/0000021175-24-000095.md) | [367 d](/filings/0000021175-26-000011.md) | [338](/filings/0000021175-25-000049.md) | [317](/filings/0000021175-25-000074.md) | [283](/filings/0000021175-25-000097.md) | [21.0 d](/filings/0000021175-26-000011.md) | [274](/filings/0000021175-26-000031.md) | [299](/filings/0000021175-26-000045.md) | [403](/filings/0000021175-25-000097.md) | [302 d](/filings/0000021175-26-000011.md) | [211](/filings/0000021175-26-000031.md) | [321](/filings/0000021175-26-000045.md) |
| Diluted EPS | $ per share | [0.95](/filings/0000021175-24-000095.md) | not reported | [1.24](/filings/0000021175-25-000049.md) | [1.17](/filings/0000021175-25-000074.md) | [1.04](/filings/0000021175-25-000097.md) | not reported | [1.00](/filings/0000021175-26-000031.md) | [1.10](/filings/0000021175-26-000045.md) | [1.48](/filings/0000021175-25-000097.md) | not reported | [0.78](/filings/0000021175-26-000031.md) | [1.18](/filings/0000021175-26-000045.md) |
| Basic EPS | $ per share | [0.95](/filings/0000021175-24-000095.md) | not reported | [1.24](/filings/0000021175-25-000049.md) | [1.17](/filings/0000021175-25-000074.md) | [1.04](/filings/0000021175-25-000097.md) | not reported | [1.01](/filings/0000021175-26-000031.md) | [1.10](/filings/0000021175-26-000045.md) | [1.49](/filings/0000021175-25-000097.md) | not reported | [0.78](/filings/0000021175-26-000031.md) | [1.18](/filings/0000021175-26-000045.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.5](/filings/0000021175-23-000065.md) | [0.3](/filings/0000021175-25-000008.md) | [0.4](/filings/0000021175-24-000039.md) | [0.4](/filings/0000021175-24-000056.md) | [0.5](/filings/0000021175-24-000095.md) | [0.5](/filings/0000021175-26-000011.md) | [0.5](/filings/0000021175-25-000049.md) | [0.4](/filings/0000021175-25-000074.md) | [0.5](/filings/0000021175-25-000097.md) | [0.4](/filings/0000021175-26-000045.md) | [0.5](/filings/0000021175-26-000031.md) | [0.3](/filings/0000021175-26-000045.md) |
| Total assets | $bn | [62.0](/filings/0000021175-23-000065.md) | [64.7](/filings/0000021175-25-000008.md) | [65.1](/filings/0000021175-24-000039.md) | [65.2](/filings/0000021175-24-000056.md) | [67.4](/filings/0000021175-24-000095.md) | [66.5](/filings/0000021175-26-000011.md) | [67.3](/filings/0000021175-25-000049.md) | [68.9](/filings/0000021175-25-000074.md) | [69.8](/filings/0000021175-25-000097.md) | [69.4](/filings/0000021175-26-000045.md) | [68.6](/filings/0000021175-26-000031.md) | [69.9](/filings/0000021175-26-000045.md) |
| Total liabilities | $bn | [53.4](/filings/0000021175-23-000065.md) | [54.8](/filings/0000021175-25-000008.md) | [55.4](/filings/0000021175-24-000039.md) | [55.3](/filings/0000021175-24-000056.md) | [56.6](/filings/0000021175-24-000095.md) | [56.0](/filings/0000021175-26-000011.md) | [57.0](/filings/0000021175-25-000049.md) | [58.3](/filings/0000021175-25-000074.md) | [58.4](/filings/0000021175-25-000097.md) | [57.8](/filings/0000021175-26-000045.md) | [57.7](/filings/0000021175-26-000031.md) | [58.7](/filings/0000021175-26-000045.md) |
| Long-term debt | $bn | [2.5](/filings/0000021175-23-000065.md) | [2.5](/filings/0000021175-25-000008.md) | [3.0](/filings/0000021175-24-000039.md) | [3.0](/filings/0000021175-24-000056.md) | [3.0](/filings/0000021175-24-000095.md) | [3.0](/filings/0000021175-26-000011.md) | [2.5](/filings/0000021175-25-000049.md) | [2.5](/filings/0000021175-25-000074.md) | [3.0](/filings/0000021175-25-000097.md) | [3.0](/filings/0000021175-26-000045.md) | [3.0](/filings/0000021175-26-000031.md) | [3.0](/filings/0000021175-26-000045.md) |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | [0.8](/filings/0000021175-23-000065.md) | [0.6](/filings/0000021175-25-000008.md) | [0.6](/filings/0000021175-24-000039.md) | [0.0](/filings/0000021175-24-000056.md) | [0.0](/filings/0000021175-24-000095.md) | [0.0](/filings/0000021175-25-000097.md) | [0.5](/filings/0000021175-25-000049.md) | [0.5](/filings/0000021175-25-000074.md) | [0.5](/filings/0000021175-25-000097.md) | not reported | not reported | not reported |
| Shareholders' equity | $bn | [8.6](/filings/0000021175-24-000095.md) | [9.9](/filings/0000021175-26-000011.md) | [9.7](/filings/0000021175-25-000049.md) | [9.9](/filings/0000021175-25-000074.md) | [10.8](/filings/0000021175-25-000097.md) | [10.5](/filings/0000021175-26-000011.md) | [10.3](/filings/0000021175-26-000031.md) | [10.7](/filings/0000021175-26-000045.md) | [11.3](/filings/0000021175-25-000097.md) | [11.6](/filings/0000021175-26-000045.md) | [10.9](/filings/0000021175-26-000031.md) | [11.2](/filings/0000021175-26-000045.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [828 d](/filings/0000021175-24-000095.md) | [520 d](/filings/0000021175-26-000011.md) | [504](/filings/0000021175-25-000049.md) | [616 d](/filings/0000021175-25-000074.md) | [748 d](/filings/0000021175-25-000097.md) | [703 d](/filings/0000021175-26-000011.md) | [638](/filings/0000021175-26-000031.md) | [562 d](/filings/0000021175-26-000045.md) | [720 d](/filings/0000021175-25-000097.md) | [570 d](/filings/0000021175-26-000011.md) | [393](/filings/0000021175-26-000031.md) | [649 d](/filings/0000021175-26-000045.md) |
| Capital expenditure | $m | [24.0 d](/filings/0000021175-24-000095.md) | [23.0 d](/filings/0000021175-26-000011.md) | [20.0](/filings/0000021175-25-000049.md) | [19.0 d](/filings/0000021175-25-000074.md) | [18.0 d](/filings/0000021175-25-000097.md) | [38.0 d](/filings/0000021175-26-000011.md) | [18.0](/filings/0000021175-26-000031.md) | [24.0 d](/filings/0000021175-26-000045.md) | [16.0 d](/filings/0000021175-25-000097.md) | [28.0 d](/filings/0000021175-26-000011.md) | [13.0](/filings/0000021175-26-000031.md) | [20.0 d](/filings/0000021175-26-000045.md) |
| Dividends paid | $m | [114 d](/filings/0000021175-24-000095.md) | [114 d](/filings/0000021175-26-000011.md) | [667](/filings/0000021175-25-000049.md) | [119 d](/filings/0000021175-25-000074.md) | [120 d](/filings/0000021175-25-000097.md) | [119 d](/filings/0000021175-26-000011.md) | [673](/filings/0000021175-26-000031.md) | [125 d](/filings/0000021175-26-000045.md) | [124 d](/filings/0000021175-25-000097.md) | [125 d](/filings/0000021175-26-000011.md) | [682](/filings/0000021175-26-000031.md) | [130 d](/filings/0000021175-26-000045.md) |
| Share repurchases | $m | [0.0 d](/filings/0000021175-24-000095.md) | [0.0 d](/filings/0000021175-26-000011.md) | [0.0](/filings/0000021175-25-000049.md) | [20.0 d](/filings/0000021175-25-000074.md) | [0.0 d](/filings/0000021175-25-000097.md) | [0.0 d](/filings/0000021175-26-000011.md) | [34.0](/filings/0000021175-26-000031.md) | [0.0 d](/filings/0000021175-26-000045.md) | [0.0 d](/filings/0000021175-25-000097.md) | [0.0 d](/filings/0000021175-26-000011.md) | [36.0](/filings/0000021175-26-000031.md) | [0.0 d](/filings/0000021175-26-000045.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q4 FY2023 (2023-03-31) | Q4 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [272](/filings/0000021175-23-000065.md) | [272](/filings/0000021175-24-000039.md) | [272](/filings/0000021175-24-000056.md) | [272](/filings/0000021175-24-000095.md) | [273](/filings/0000021175-25-000049.md) | [273](/filings/0000021175-25-000074.md) | [273](/filings/0000021175-25-000097.md) | [273](/filings/0000021175-26-000031.md) | [272](/filings/0000021175-26-000045.md) | [272](/filings/0000021175-25-000097.md) | [272](/filings/0000021175-26-000031.md) | [272](/filings/0000021175-26-000045.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 270,600,928 at 2026-07-30, from the cover of the [10-Q filed 2026-08-03](/filings/0000021175-26-000045.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.